Mankind Pharma - About the company
Mankind Pharma is a public company based in Delhi (India), founded in 1991 by Rajeev Juneja and Ramesh C Juneja. It operates as a Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations. Mankind Pharma has raised $367M in funding from ChrysCapital and Monet. The company has 205 active competitors, including 13 funded and 53 that have exited. Its top competitors include companies like Bayer, Wockhardt and Lupin.
Company Details
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations. It focuses on a diverse range of therapeutic areas, catering to both acute and chronic conditions, include Anti-infectives, Cardiovascular, Gastrointestinal, Respiratory, Vitamins, Minerals, and Nutrients, Anti-diabetic, Neuro/Central Nervous System, and Gynaecology. Its most notable brands include Nurokind, Telmikind, Moxikind, Amlokind, and Gudcef.
- Website
- www.mankindpharma.com/
- Social
- Email ID
- *****@mankindpharma.com
- Phone Number
- +91 **********
- Registered Address
- 208, Okhla Industrial Estate, Phase-III, South Delhi, New Delhi, Delhi, India, 110020
Key Metrics
Founded Year
1991
Location
Delhi, India
Stage
Public
Total Funding
$367M in 2 rounds
Latest Funding Round
Investors
Ranked
11th among 205 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2026
Employee Count
20,428 as on Mar 31, 2026
Exit Details
Public
Legal entities associated with Mankind Pharma
Mankind Pharma is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
MANKIND LIFE SCIENCES PRIVATE LIMITED CIN: U24100DL2020PTC369904 , India, Active | Sep 14, 2020 | ₹50 - ₹100 Cr (As on Mar 31, 2026) | - | |
MANKIND PRIME LABS PRIVATE LIMITED CIN: U51909DL2020PTC370864 , India, Active | Oct 03, 2020 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 217 (As on Feb 29, 2024) | |
MAGNET LABS PRIVATE LIMITED CIN: U51397DL1998PTC093307 , India, Amalgamated | Apr 17, 1998 | ₹100 - ₹500 Cr (As on Mar 31, 2022) | 966 (As on Mar 31, 2022) | |
MANKIND PHARMA LIMITED CIN: L74899DL1991PLC044843 , India, Active | Jul 03, 1991 | ₹1,000+ Cr (As on Mar 31, 2026) | 19532 (As on Jun 30, 2025) |
Mankind Pharma's IPO details
Mankind Pharma got listed on May 09, 2023.
Click here to take a look at Mankind Pharma's IPO in detail
Sign up to download Mankind Pharma's company profile
Mankind Pharma's funding and investors
Mankind Pharma has raised a total funding of $367M over 2 rounds. Its first funding round was on Apr 23, 2007. Its latest funding round was a PE round on Apr 02, 2018 for $*****. 1 investor participated in its latest round. Mankind Pharma has 12 institutional investors and 4 angel investors.
Here is the list of recent funding rounds of Mankind Pharma:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 02, 2018 | 8337967 | PE | 1403490 | 8341687 | 8280167 | 3785836 |
Apr 23, 2007 | 4880856 | Series A | 4856311 | 3278426 | 2879229 |
Access funding benchmarks and valuations. Sign up today!View details of Mankind Pharma's funding rounds and investors
Mankind Pharma's founders and board of directors
Founder? Claim ProfileThe founders of Mankind Pharma are Rajeev Juneja and Ramesh C Juneja. Sheetal Arora is the CEO of Mankind Pharma.
Here are the details of Mankind Pharma's key team members:
- Rajeev Juneja: Co-Founder & MD of Mankind Pharma and founder of 3 other companies, Manforce Condoms, Mediforce Healthcare and Mankind Group Family office. They are also an angel investor in 9 startups and serve on the board of 1 company.
- Ramesh C Juneja: Co-Founder of Mankind Pharma and founder of 3 other companies, Mediforce Healthcare, Manforce Condoms and Mankind Group Family office. They are also an angel investor in 1 startup and serve on the board of 1 company.Contact Info: 1 email address and 1 phone number
- Sheetal Arora: CEO of Mankind Pharma. Contact Info: 2 email addresses and 1 phone number
Mankind Pharma's Board of Directors
Mankind Pharma's board has 7 active members. Rajeev Juneja, Sheetal Arora and Ramesh C Juneja are part of team and Anish Vanraj Bafna, Vijaya Sampath, Tilokchand Punamchand Ostwal and Vivek Kalra are independent board members.Here is the list of Mankind Pharma's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 33y 10m | |
Team | - | Current | 35y 4m | |
{bouqwn | Team | - | Current | 4y 8m |
Independent board member | - | Current | 0y 2m | |
ycjkxct | Independent board member | - | Current | 7y 2m |
weeosey | Independent board member | - | Current | 2y 2m |
trqobgu | Independent board member | - | Current | 1y 2m |
View details of Mankind Pharma's Founder profiles and Board Members
Mankind Pharma's employee count trend
Mankind Pharma has 20,428 employees as of Mar 26. Here is Mankind Pharma's employee count trend over the years:
Uncover Mankind Pharma's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Mankind Pharma's Competitors and alternates
Top competitors of Mankind Pharma include Bayer, Wockhardt and Lupin. Here is the list of Top 10 competitors of Mankind Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Manufacturer of drugs | - | 76/100 | ||
2nd | Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients | - | 71/100 | ||
3rd | Manufacturer of pharmaceutical products, including generics, biosimilars, and active pharmaceutical ingredients | $6.64M | 71/100 | ||
4th |  Biological E 1953, Hyderabad (India), Funding Raised | Developer of vaccines for treating multiple diseases | - | 69/100 | |
5th | Manufacturer of APIs, generic drugs, and formulation development services | - | 69/100 | ||
6th | Developer, manufacturer, and markets a broad range of pharmaceutical products | $50M | 68/100 | ||
7th | Amneal 2002, Bridgewater (United States), Public | Manufacturer of generics formulations | - | 68/100 | |
8th | Strides Pharma Science 1990, Bengaluru (India), Public | Manufacturer of generic pharmaceutical products and various specialty medical formulations | - | 68/100 | |
9th |  Aurobindo Pharma 1986, Hyderabad (India), Public | Provider of generic biocatalytic products | - | 66/100 | |
10th |  Dr. Reddy's Laboratories 1984, Hyderabad (India), Public | Multinational pharmaceutical company that develops and manufactures innovative and medicines to improve patient health | - | 65/100 | |
11th |  Mankind Pharma 1991, Delhi (India), Public | Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | $367M | 65/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Mankind Pharma's competitors? Click here to see the top ones
Financials of Mankind PharmaFY 26 Available
MANKIND PHARMA LIMITED, the legal entity associated with Mankind Pharma, generated more than ₹1,000 Cr in revenue for the financial year ending on Mar 31, 2026. The revenue of MANKIND PHARMA LIMITED has a compounded annual growth rate (CAGR) of 15% in the last 1 year.
Financial Statement Summary
Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 4672 | 6700 | 9530 | 5705 | 7311 |
Total Sales | 2634 | 5957 | 1082 | 1557 | 4673 |
Total Expenses | 7194 | 1447 | 8150 | 6026 | 2406 |
Operating Expenses | 8074 | 8184 | 6878 | 1116 | 5129 |
Employee Expenses | 2982 | 1108 | 5171 | 2402 | 4932 |
Marketing Expenses | 7855 | 7301 | 5722 | 7384 | 6471 |
Operating Income (EBIT) | 8761 | 1925 | 3582 | 1929 | 1647 |
Interest Expenses | 3283 | 3632 | 9484 | 6616 | 2962 |
Expenses from other activities | 8553 | 9285 | 5690 | 4272 | 6238 |
Information Technology Expenses | 3201 | 7897 | 9386 | 7861 | 9411 |
EBITDA | 8648 | 2891 | 8830 | 5107 | 2215 |
Taxes | 1787 | 1380 | 3036 | 8179 | 4768 |
Net Profit | 5267 | 9930 | 4767 | 2905 | 9698 |
Balance Sheet | |||||
Assets | 6726 | 4600 | 4715 | 9348 | 5512 |
Cash Equivalent | 1457 | 8317 | 1191 | 8568 | 9505 |
Accounts Receivables | 1700 | 9237 | 4558 | 4573 | 8972 |
Inventory | 9841 | 7528 | 6461 | 2029 | 9718 |
Liabilities | 5603 | 9759 | 1184 | 4753 | 4914 |
Total Debt | 7828 | 5553 | 7721 | 8102 | 4821 |
Accounts Payable | 5444 | 2598 | 9127 | 8397 | 2565 |
Equities | 3131 | 8070 | 1042 | 6305 | 4017 |
Cashflow Statement | |||||
Cash from Operating activities | 5894 | 4833 | 3290 | 9401 | 2717 |
Cash from Investing activities | 2875 | 7858 | 4517 | 4094 | 9570 |
Net cash from Financing activities | 6563 | 9163 | 2757 | 9352 | 5664 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Mankind Pharma's Investments and acquisitions
Mankind Pharma has made 11 investments in companies including Actimed Therapeutics and BatX Energies. Mankind Pharma has also acquired 4 companies including BSV and Upakarma.Here is the list of investments & acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 25, 2024 | Acquisition | 1971 | Navi Mumbai (India) | |
Dec 15, 2023 | Investments | 2017 | London (United Kingdom) | |
Aug 31, 2023 | Investments | 2020 | Gurugram (India) |
Want to know more about where corporates are investing? Sign up today!See all investments and acquisitions by Mankind Pharma
Reports related to Mankind Pharma
Here is the latest report on Mankind Pharma's geography:
News related to Mankind Pharma
Filter this listMedia has covered Mankind Pharma for a total of 25 events in the last 1 year, 8 of them have been about company updates and 2 about partnerships.
•
Mankind Pharma's quarterly profit jumps 39% on strong chronic drugReuters•Oct 26, 2026•Mankind Pharma
•
Mankind Pharma Q2 FY27 Revenue Up 17.3% To Rs 4,338 Crore, PAT Margin ImprovesIndiatimes•Oct 26, 2026•Mankind Pharma
•
Mankind Pharma to acquire 70% stake in Belgium's Armed Cell Therapeutics for EUR 48 millionBusinessFortNight•Oct 15, 2026•Mankind Pharma, ActX
•
Mankind Pharma Launches "Angdaan Mahadaan" to Inspire 1 Crore Indians to Pledge for Organ DonationOdishaDiary•Sep 03, 2026•Mankind Pharma
•
Mankind Pharma sells 100% stake in Broadway Hospitality Services for Rs 49 croreIndiatimes•Aug 31, 2026•Mankind Pharma
•
Mankind Pharma Ltd (NSE:MANKIND) (Q1 2027) Earnings Call Highlights: Chronic Portfolio Surges ...Yahoo•Aug 01, 2026•Mankind Pharma
•
Mankind Pharma and Denovo Sciences Partner for AI-Led Drug DiscoveryIndiaMedToday•Jul 02, 2026•Mankind Pharma
•
BatX Energies Raises Rs 105 Cr in Series A Funding Led by IvyCap VenturesEntrackr•Jul 02, 2026•BatX Energies, IvyCap Ventures, Mankind Pharma, Zephyr Management
•
Mankind Pharma's arm acquires remaining 10% stake in Upakarma Ayurveda for Rs 75 lakhUdaipur Kiran•Jun 03, 2026•Upakarma, Mankind Pharma
•
Mankind Pharma focuses on domestic manufacturing and chronic therapies.Indiatimes•Apr 17, 2026•Mankind Pharma
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Mankind Pharma
Explore our recently published companies
- Homeschool Facts - Unfunded company
- Canbas Bio - Tangerang based, 2018 founded, Unfunded company
- BioNordika - Finland based, 1995 founded, Public company
- Shangkentech.com - 2018 founded, Unfunded company
- Innovsense.com - 2022 founded, Unfunded company
- Jupho - Mumbai based, Unfunded company
